Kamper, A M <br/><br/>
Safety of combining ticlopidine with nadroparin in the routine treatment of chronic hemodialysis patients.  [electronic resource] 

 -  Nephron  1997 
 - 484-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1660-8151 
<br/><br/><label>Standard No.: </label>10.1159/000190330  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Combinations<br/>Humans<br/>Kidney Failure, Chronic--complications<br/>Nadroparin--adverse effects<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Renal Dialysis<br/>Ticlopidine--adverse effects